In conclusion, PRCP protects against myocardial I/R injury via a paradoxical regulation of cardiomyocyte mitophagy during ischemia and reperfusion phases, and its effects depend on downstream Ang-(1–7) and BK-(1–9). The gene discussed is KNG1; the disease is ischemia.